University of SaskatchewanHARVEST
  • Login
  • Submit Your Work
  • About
    • About HARVEST
    • Guidelines
    • Browse
      • All of HARVEST
      • Communities & Collections
      • By Issue Date
      • Authors
      • Titles
      • Subjects
      • This Collection
      • By Issue Date
      • Authors
      • Titles
      • Subjects
    • My Account
      • Login
      JavaScript is disabled for your browser. Some features of this site may not work without it.
      View Item 
      • HARVEST
      • Electronic Theses and Dissertations
      • Graduate Theses and Dissertations
      • View Item
      • HARVEST
      • Electronic Theses and Dissertations
      • Graduate Theses and Dissertations
      • View Item

      EQUINE PITUITARY PARS INTERMEDIA DYSFUNCTION (PPID): PATHOPHYSIOLOGY AND A SURGICAL APPROACH TO TREATMENT

      Thumbnail
      View/Open
      CARMALT-DISSERTATION-2017.pdf (2.343Mb)
      Date
      2017-07-11
      Author
      Carmalt, James L 1973-
      Type
      Thesis
      Degree Level
      Doctoral
      Metadata
      Show full item record
      Abstract
      Equine pituitary pars intermedia dysfunction (PPID) is a common endocrine disease of the older horse. First described in 1932, and likened to human Cushing’s disease, it is associated with an enlargement of the pituitary gland that was classically termed an adenoma. The underlying mechanism is attributable to a lack of dopaminergic inhibition of the pars intermedia. Treatment methods have remained essentially unchanged for 30 years and the prevalence data have mainly stemmed from Eastern Australia and the USA. The general objective of this thesis was to explore the feasibility of developing a targeted cell-specific approach for the treatment of equine PPID. The specific aims were to confirm the need for this advanced therapy by determining the prevalence of PPID in horses globally; to continue the investigation of the underlying cellular mechanism of PPID by confirming the role of pro-hormone convertases, and sequence the equine pro-opiomelanocortin, prohormone convertase 1 and 2 genes; and to investigate the methodology for site-specific applications of future therapy for equine PPID. These aims were met by reporting the prevalence data from a worldwide audience of veterinarians using an internet-based survey tool; by describing partial gene sequences of the equine proopiomelanocortin and prohormone convertase enzymes and their expression in normal and PPID horses; and by showing how low-volume contrast enhancement of the brain using computed tomography can delineate the margins of the pituitary gland, showing how general anesthesia effects the pulsitility and concentration of adrenocorticotrophic hormone, and finally, modifying a previously reported technique, by developing a novel surgical approach to the treatment of this classical condition.
      Degree
      Doctor of Philosophy (Ph.D.)
      Department
      Veterinary Pathology
      Program
      Veterinary Pathology
      Supervisor
      Allen, Andrew L
      Committee
      Unniappan, Suraj; Muir, Gillian; Campbell, John; Shmon, Cindy; Simko, Elemir
      Copyright Date
      June 2017
      URI
      http://hdl.handle.net/10388/7952
      Subject
      Equine
      PPID
      Cushings Disease
      Pathophysiology
      Surgery
      Treatment
      Collections
      • Graduate Theses and Dissertations
      University of Saskatchewan

      University Library

      © University of Saskatchewan
      Contact Us | Disclaimer | Privacy